← Back to Search

Cognitive Training for Parkinson's Disease

N/A

Recruiting

Led By Sule Tinaz, MD, PhD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥ 40 years

Diagnosis of idiopathic PD

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at baseline, 6 weeks, and 12 weeks.

Awards & highlights

Study Summary

This trialwill explore if cognitive training can help people with PD better manage daily tasks by testing their brain & cognitive skills.

Who is the study for?

This trial is for people over 40 with Parkinson's Disease who are on stable medication. Participants must speak English, not be pregnant or breastfeeding, have no excessive alcohol use, and no metal implants that affect MRI scans. They should be able to lie flat for an hour and not have severe cognitive impairments or other neurological disorders.Check my eligibility

What is being tested?

The study tests if mental imagery training and psychoeducation can improve thinking skills and brain function in daily activities for those with Parkinson's. It involves cognitive assessments and MRIs to measure the effects of the interventions.See study design

What are the potential side effects?

Since this trial focuses on non-invasive cognitive training rather than medication, traditional side effects like nausea or headaches aren't expected. However, participants may experience fatigue or discomfort from long periods of concentration or lying still during MRI scans.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 40 years old or older.

Select...

I have been diagnosed with Parkinson's disease.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at baseline, 6 weeks, and 12 weeks.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at baseline, 6 weeks, and 12 weeks.

This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, 6 weeks, and 12 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Quality of life in Neurological Disorders (Neuro-QoL) Version 2 Cognitive Function scores

Brain

Secondary outcome measures

Change in composite executive function test scores

Change in local and global functional connectivity-based graph measures

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Mental ImageryExperimental Treatment1 Intervention

Group II: PsychoeducationActive Control1 Intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor

1,851 Previous Clinical Trials

2,738,201 Total Patients Enrolled

National Institute of Neurological Disorders and Stroke (NINDS)NIH

1,340 Previous Clinical Trials

649,239 Total Patients Enrolled

Sule Tinaz, MD, PhDPrincipal InvestigatorYale University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor presently seeking volunteers?

"This clinical trial is in the process of enrolling patients. According to information available on clincialtrials.gov, it was first posted and last updated on January 13th 2023."

Answered by AI

What is the current enrollment rate of this clinical research?

"Indeed, clinicaltrials.gov lists this medical trial as being actively recruiting patients. The study was first posted on January 13th 2023 and was most recently amended the same day. Currently, it is seeking 120 participants from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Cognitive Training in Parkinson's Disease

2023. "Cognitive Training in Parkinson's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05495997.